AstraZeneca AustraliaAstraZeneca is one of Australia’s largest private sector investors in medical research and development (R&D) and has, invested more than $250 million in Australia in the last decade.
As the largest national manufacturer of pharmaceuticals, AstraZeneca provides $1.2 billion of medicines to the local market and $200 million in exports.
The company is currently involved in more than 50 clinical trials at over 200 sites across Australia, investigating potential new treatments in the areas of oncology, cardiovascular, diabetes, infection, gastrointestinal, neuroscience, respiratory, and inflammation. AstraZeneca employs more than 900 people in Australia.
